Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain ...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from CEimpact Podcast
Reassessing Tramadol Use in Chronic Pain
Safe and Informed Use of Melatonin in Pediatric Patients
A Review of Acute Rescue Therapies in Clinical Practice
Practical Updates From the New Cholesterol Guidelines
Get summaries like this every morning.
Free AI-powered recaps of CEimpact Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.